Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors
Clinical trial NCT00276575 · COMPLETED
Trial details
- NCT number
- NCT00276575
- Sponsor
- Herbert Hurwitz, MD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-03-01
- Primary completion
- 2012-10-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.